Add to ORKGThe Author(s) 2013. This article is published with open access at Springerlink.com Introduction: Saxagliptin, sitagliptin, and vildagliptin are dipeptidyl peptidase-4 (DPP-4) inhibitors widely approved for use in patients with type 2 diabetes. Using a crossover design, the present study compared trough levels o
Peter P Toth1,2 1CGH Medical Center, Sterling IL, USA, 2Johns Hopkins University School of Medicine,...
Inhibition of dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (G...
BackgroundWe evaluated the effects of two dipeptidyl peptidase-4 (DPP-4) inhibitors, sitagliptin and...
Mary Elizabeth Cox1, Jennifer Rowell1, Leonor Corsino1, Jennifer B Green1,21Department of Medicine, ...
Type 2 diabetes mellitus (T2DM) is a global epidemic with increasing impact on individuals and healt...
Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christian LerchCochrane Metabolic and E...
The Author(s) 2014. This article is published with open access at Springerlink.com Introduction: The...
Type 2 diabetes mellitus (T2DM) is a global epidemic with increasing impact on individuals and healt...
INTRODUCTION: Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used in the management of patient...
Aims/hypothesis There are limited data comparing dipeptidyl peptidase-4 (DPP-4) inhibitors directly....
Baptist GallwitzDept Medicine IV, Tübingen University, Otfried-Müller-Str, 10, 72076 T&uum...
Dipeptidyl peptidase 4 (DPP4) inhibitors have been touted as promising antihyperglycemic agents due ...
The introduction of DPP-4 inhibitors substantially increased therapeutic options for type 2 diabetes...
Type 2 diabetes mellitus (T2DM) is a global epidemic with increasing impact on individuals and healt...
Introduction: The dipeptidyl peptidase-4 inhibitors (DPP-4is), which belong to the class of incretin...
Peter P Toth1,2 1CGH Medical Center, Sterling IL, USA, 2Johns Hopkins University School of Medicine,...
Inhibition of dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (G...
BackgroundWe evaluated the effects of two dipeptidyl peptidase-4 (DPP-4) inhibitors, sitagliptin and...
Mary Elizabeth Cox1, Jennifer Rowell1, Leonor Corsino1, Jennifer B Green1,21Department of Medicine, ...
Type 2 diabetes mellitus (T2DM) is a global epidemic with increasing impact on individuals and healt...
Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christian LerchCochrane Metabolic and E...
The Author(s) 2014. This article is published with open access at Springerlink.com Introduction: The...
Type 2 diabetes mellitus (T2DM) is a global epidemic with increasing impact on individuals and healt...
INTRODUCTION: Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used in the management of patient...
Aims/hypothesis There are limited data comparing dipeptidyl peptidase-4 (DPP-4) inhibitors directly....
Baptist GallwitzDept Medicine IV, Tübingen University, Otfried-Müller-Str, 10, 72076 T&uum...
Dipeptidyl peptidase 4 (DPP4) inhibitors have been touted as promising antihyperglycemic agents due ...
The introduction of DPP-4 inhibitors substantially increased therapeutic options for type 2 diabetes...
Type 2 diabetes mellitus (T2DM) is a global epidemic with increasing impact on individuals and healt...
Introduction: The dipeptidyl peptidase-4 inhibitors (DPP-4is), which belong to the class of incretin...
Peter P Toth1,2 1CGH Medical Center, Sterling IL, USA, 2Johns Hopkins University School of Medicine,...
Inhibition of dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (G...
BackgroundWe evaluated the effects of two dipeptidyl peptidase-4 (DPP-4) inhibitors, sitagliptin and...